CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Long Term Provisions | ₹66 Cr | ₹39 Cr | ₹32 Cr | ₹25 Cr |
What is the latest Long Term Provisions ratio of CORONA REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹66 Cr |
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹25 Cr |
How is Long Term Provisions of CORONA REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹66 Cr | 71.12 | |
| Mar2025 | ₹39 Cr | 20.55 | |
| Mar2024 | ₹32 Cr | 29.12 | |
| Mar2023 | ₹25 Cr | - | |
Compare Long Term Provisions of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,384.7 Cr | -0.8% | -8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -0.8% |
-8% |
|
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses